Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CRISPR Therapeutics AG (CRSP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
63.79+3.02 (+4.97%)
At close: 04:00PM EDT
63.46 -0.33 (-0.52%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close60.77
Open61.11
Bid62.55 x 1000
Ask63.79 x 1200
Day's Range60.41 - 64.00
52 Week Range42.51 - 155.87
Volume947,769
Avg. Volume1,753,562
Market Cap4.882B
Beta (5Y Monthly)2.01
PE Ratio (TTM)12.12
EPS (TTM)5.26
Earnings DateApr 25, 2022 - Apr 29, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est121.86
  • TheStreet.com

    CRISPR Therapeutics Has Turned the Corner

    The leading gene editing company CRISPR Therapeutics is looking better to technically oriented traders. Let's take a look. In this daily bar chart of CRSP, below, we can see that following a downtrend that prices have turned sideways since January.

  • Motley Fool

    3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

    Vaxart (NASDAQ: VXRT) is working on a coronavirus vaccine candidate. Recently, Vaxart said its omicron-specific candidate and its original candidate both protected against the variant in preclinical tests. Of course, even if Vaxart is successful, the company will make it to market much later than bigger rivals.

  • Zacks

    A Comprehensive Guide to Genomic ETFs

    Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.

Advertisement
Advertisement